Craft

Gliknik

Total Funding

$65.1 M

Gliknik Summary

Company Summary

Overview
Gliknik is a biopharmaceutical company creating therapies for people living with cancer and immune disorders. It offers stradomer and stradobody programs.
Type
Private
Status
Active
Founded
2007
HQ
Baltimore, MD, US | view all locations
Website
http://www.gliknik.com
Cybersecurity rating
Sectors

Key People

  • David S. Block

    David S. Block, Chairman and CEO

    • Henrik S. Olsen

      Henrik S. Olsen, Vice President, Drug Discovery

      • Paul A. Friedman

        Paul A. Friedman, Non-Executive Director

        • Mark D. Lerner

          Mark D. Lerner, Non-Executive Director

          LocationsView all

          1 location detected

          • Baltimore, MD HQ

            United States

            801 W Baltimore St #501a

          Footer menu